Anagram Therapeutics

Biotechnology company · Framingham, Massachusetts, United States

Anagram Therapeutics is a biotechnology company headquartered in Framingham, Massachusetts, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.8 million in total, most recently in 2022.

www.synspira.comProfile compiled from public records. Is this your company? Request a correction or update

Anagram Therapeutics at a glance

Typebiotechnology company

HeadquartersFramingham, Massachusetts, United States

Employees (self-reported, 2022)9

What does Anagram Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $1.8 million in total (2022). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Frequently asked questions about Anagram Therapeutics

Where is Anagram Therapeutics headquartered?

Anagram Therapeutics is headquartered in Framingham, Massachusetts, United States.

What does Anagram Therapeutics do?

Anagram Therapeutics is a biotechnology company.

Similar companies

Boston Heart Diagnostics CorpFramingham, Massachusetts, United States
Bessor Pharma, LLCFramingham, Massachusetts, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences